MTOR and gastric cancer: While, a recent study revealed that lncRNA FOXD1-AS1 could strengthen the interaction of eIF4E with eIF4G by activating the PI3K/AkT/mTOR pathway to promote gastric cancer progression and cisplatin resistance [46].